About Presidio Medical
We are a clinical-stage medical device company developing a platform neuromodulation technology to treat diseases of undesired neural activity. Our initial indication is chronic pain.
In the US alone approximately 50 million individuals suffer from chronic pain with treatment and productivity costs totaling more than $500 billion each year. Despite the mortality associated with opiate use, in 2018 there were over 168 million opiate prescriptions in the US according to the Centers for Disease Control (CDC) highlighting the need for better therapies.